Apoptosis-inducing activity of the S100A8/A9 heterodimer

Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2009, Pages 318-328

  Hashemi, Mohammad ^a,b   Chitayat, Seth ^c   Ande, Sudharsana Rao ^d   Chazin, Walter J ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Apoptosis; Calprotectin; S100A8 A9; Zinc

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIINFLAMMATORY AGENT; CALGRANULIN A; CALGRANULIN B; CASPASE 10; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; DEATH RECEPTOR 3; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ANTIGEN; GRANZYME B; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GB3.1; PENTETIC ACID; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 10; PROTEIN BCL 2; PROTEIN BID; QUINOLINE 3 CARBOXAMIDE DERIVATIVE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SERINE PROTEINASE OMI; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOIMMUNE DISEASE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL DEATH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHELATION THERAPY; CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR IMMUNITY;

EID: 73649114605     PISSN: 18715230     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152309789838993     Document Type: Review

References (94)

1. Kerkhoff, C.; Klempt, M., Sorg, C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim. Biophys. Acta, 1998, 1448(2), 200-11.
2. Klempt, M.; H. Melkonyan; W. Nacken; D. Wiesmann; U. Holtkemper, and C. Sorg. The heterodimer of the Ca2+-binding proteins MRP8 and MRP14 binds to arachidonic acid. FEBS Lett., 1997, 408(1), 81-4.
3. Rammes, A.; Roth J.; Goebeler, M.; Klempt, M.; Hartmann M., Sorg, C. Myeloid-related protein (MRP) 8 and MRP14, calciumbinding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J. Biol. Chem., 1997, 272(14), 9496-9502.
4. Yui, S.; Mikami, M.; Tsurumaki, K.; Yamazaki, M. Growthinhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions. J. Leukoc. Biol., 1997, 6(1), 50-57.
5. Zaia, A.A.; Sappington, K.J.; Nisapakultorn, K.; Chazin, W.J.; Dietrich, E.A.; Ross, K.F., Herzberg, M.C. Subversion of antimicrobial calprotectin (S100A8/S100A9 complex) in the cytoplasm of TR146 epithelial cells after invasion by Listeria monocytogenes. Mucosal Immunol., 2009, 2(1), 43-53.
6. Turovskaya, O.; Foell, D.; Sinha, P.; Vogl, T.; Newlin, R.; Nayak, J.; Nguyen, M.; Olsson, A.; Nawroth, P.P.; Bierhaus, A.; Varki, N.; Kronenberg, M.; Freeze, H. H.; Srikrishna, G. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis, 2008, 29(10), 2035-2043.
7. Ehrchen, J.M.; Sunderkotter, C.; Foell, D.; Vogl, T.; Roth, J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J. Leukoc. Biol., 2009, 86(3), 557-563.
8. Yui, S.; Nakatani, Y.; Mikami, M. Calprotectin (S100A8/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity. Biol. Pharm. Bull., 2003, 26(6), 753-760.
9. Ghavami, S.; Kerkhoff, C.; Los, M.; Hashemi, M.; Sorg, C.; Karami-Tehrani, F. Mechanism of apoptosis induced by S100A8/ A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol., 2004, 76(1), 169-175.
10. Ghavami, S.; Kerkhoff, C.; Chazin, W.J.; Kadkhoda, K.; Xiao, W.; Zuse, A.; Hashemi, M.; Eshraghi, M.; Schulze-Osthoff, K.; Klonisch, T.; Los, M. S100A8/9 induces cell death via a novel, RAGEindependent pathway that involves selective release of Smac/ DIABLO and Omi/HtrA2. Biochim. Biophys. Acta, 2008, 1783(2), 297-311.
11. Zali, H.; Rezaei-Tavirani, M.; Kariminia, A.; Yousefi, R.; Shokrgozar, M.A. Evaluation of growth inhibitory and apoptosis inducing activity of human calprotectin on the human gastric cell line (AGS). Iran Biomed. J., 2008, 12(1), 7-14.
12. Yui, S.; Mikami, M.; Yamazaki, M. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells. J. Leukoc. Biol., 1995, 58(6), 650-658.
13. Nakatani, Y.; Yamazaki, M.; Chazin, W.J.; Yui, S. Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity. Mediators Inflamm., 2005, 2005(5), 280-292.
14. Yui, S.; Nakatani, Y.; Hunter, M.J.; Chazin, W.J.; Yamazaki, M. Implication of extracellular zinc exclusion by recombinant human calprotectin (MRP8 and MRP14) from target cells in its apoptosisinducing activity. Mediators Inflamm, 2002, 11(3), 165-172.
15. Hashemi, M.; Kroczak, T.J. Apoptosis and autoimmune disease. Curr. Med. Chem. - Anti-Inflamm. Anti-Allergy Agents, 2005, 4, 429-437.
16. Ghavami, S.; Hashemi, M.; Ande, S. R.; Yeganeh, B.; Xiao, W.; Eshraghi, M.; Bus, C. J.; Kadkhoda, K.; Wiechec, E.; Halayko, A. J.; Los, M. Apoptosis and cancer: mutations within caspase genes. J. Med. Genet., 2009, 46(8), 497-510.
17. Salvesen, G.S.; Dixit, V.M. Caspases: intracellular signaling by proteolysis. Cell, 1997, 91(4), 443-446.
18. Thornberry, N.A.; Lazebnik, Y. Caspases: enemies within. Science, 1998, 281(5381), 1312-1316.
19. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol., 2007, 35(4), 495-516.
20. Lavrik, I.N.; Golks, A.; Krammer, P.H. Caspases: pharmacological manipulation of cell death. J. Clin. Invest., 2005, 115(10), 2665-2672.
21. Boldin, M.P.; Goncharov, T.M.; Goltsev, Y.V.; Wallach, D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell, 1996, 85(6), 803-815.
22. Kischkel, F.C.; Hellbardt, S.; Behrmann, I.; Germer, M.; Pawlita, M.; Krammer, P.H.; Peter, M.E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J., 1995, 14(22), 5579-5588.
23. Ashkenazi, A.; Dixit, V.M. Death receptors: signaling and modulation. Science, 1998, 281(5381), 1305-1308.
24. Luo, X.; Budihardjo, I.; Zou, H.; Slaughter, C.; Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 1998, 94(4), 481-490.
25. Li, H.; H. Zhu; C.J. Xu, and J. Yuan. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 1998, 94(4), 491-501.
26. Hashemi, M.; Ghavami, S.; Eshraghi, M.; Booy, E.P.; Los, M. Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. Eur. J. Pharmacol., 2007, 557(1), 9-19.
27. Hashemi, M.; Karami-Tehrani, F.; Ghavami, S.; Maddika, S.; Los, M. Adenosine and deoxyadenosine induces apoptosis in oestrogen receptor-positive and -negative human breast cancer cells via the intrinsic pathway. Cell Prolif., 2005, 38(5), 269-285.
28. Roos, W.P.; Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol. Med., 2006, 12(9), 440-450.
29. Chipuk, J.E.; Fisher, J.C.; Dillon, C.P.; Kriwacki, R.W.; Kuwana, T.; Green, D.R. Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc. Natl. Acad. Sci. USA, 2008, 105(51), 20327-20332.
30. Chipuk, J.E.; Green, D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol., 2008, 18(4), 157-164.
31. Youle, R.J.; Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol., 2008, 9(1), 47-59.
32. Cai, J.; Yang, J., Jones, D.P. Mitochondrial control of apoptosis: the role of cytochrome c. Biochim. Biophys. Acta, 1998, 1366(1-2), 139-149.
33. Saikumar, P.; Mikhailova, M.; Pandeswara, S.L. Regulation of caspase-9 activity by differential binding to the apoptosome complex. Front Biosci., 2007, 12, 3343-3354.
34. Orrenius, S.; Gogvadze, V.; Zhivotovsky, B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol., 2007, 47, 143-183.
35. van Loo, G.; Saelens, X.; van Gurp, M.; MacFarlane, M.; Martin, S.J.; Vandenabeele, P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ., 2002, 9(10), 1031-1042.
36. Schimmer, A.D. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res., 2004, 64(20), 7183-7190.
37. Shiozaki, E.N.; Shi, Y. Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem. Sci., 2004, 29(9), 486-494.
38. Kerkhoff, C.; Ghavami, S. Induction of apoptotic cell death in tumor cells by S100A8/A9 released from inflammatory cells upon cellular activation. Curr. Med. Chem-Anti-Inflamm. Anti-Allergy Agents, 2005, 4(4), 383-391.
39. Robinson, M.J.; Tessier, P.; Poulsom, R.; Hogg, N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem., 2002, 277(5), 3658-3665.
40. Eue, I.; Konig, S.; Pior, J.; Sorg, C. S100A8, S100A9 and the S100A8/A9 heterodimer complex specifically bind to human endothelial cells: identification and characterization of ligands for the myeloid-related proteins S100A9 and S100A8/A9 on human dermal microvascular endothelial cell line-1 cells. Int. Immunol., 2002, 14(3), 287-297.
41. Siegenthaler, G.; Roulin, K.; Chatellard-Gruaz, D.; Hotz, R.; Saurat, J.H.; Hellman, U.; Hagens, G. A heterocomplex formed by the calcium-binding proteins MRP8 (S100A8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity. J. Biol. Chem., 1997, 272(14), 9371-9377.
42. Kerkhoff, C.; Sorg, C.; Tandon, N.N.; Nacken, W. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry, 2001, 40(1), 241-248.
43. Hermani, A.; Servi, B. De.; Medunjanin, S.; Tessier, P.A.; Mayer, D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res., 2006, 312(2), 184-197.
44. Ghavami, S.; Rashedi, I.; Dattilo, B.M.; Eshraghi, M.; Chazin, W.J.; Hashemi, M.; Wesselborg, S.; Kerkhoff, C., Los, M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol., 2008, 83(6), 1484-1492.
45. Griffiths, M.J.; McAuley, D.F. RAGE: a biomarker for acute lung injury. Thorax, 2008, 63(12), 1034-1036.
46. Kalea, A.Z.; Schmidt, A.M.; Hudson, B.I. RAGE: a novel biological and genetic marker for vascular disease. Clin. Sci. (Lond)., 2009, 116(8), 621-637.
47. Leclerc, E.; Fritz, G.; Vetter, S.W.; Heizmann, C.W. Binding of S100 proteins to RAGE: an update. Biochim. Biophys. Acta, 2009, 1793(6), 993-1007.
48. Sparvero, L.J. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J. Transl. Med., 2009, 7, 17.
49. Ghavami, S.; Eshraghi, M.; Chazin, W.J.; Klonisch, T.; Halayko, A.J.; Hashemi, M.; Kerkhoff, C.; Mcneill, K., Los, M. S100A8/A9 induces autophagy and apoptosis via ROS mediated cross-talk between mitochondria and lysosomes and it involves BNIP3. Cell Res., 2009, In Press.
50. Kretsinger, R.H.; Nockolds, C.E. Carp muscle calcium-binding protein. II. Structure determination and general description. J. Biol. Chem., 1973, 248(9), 3313-3326.
51. Strynadka, N.C.; James, M.N. Crystal structures of the helix-loophelix calcium-binding proteins. Annu. Rev. Biochem., 1989, 58, 951-998.
52. Potts, B.C.; Smith, J.; Akke, M.; Macke, T.J.; Okazaki, K.; Hidaka, H.; Case, D.A., Chazin, W.J. The structure of calcyclin reveals a novel homodimeric fold for S100 Ca(2+)-binding proteins. Nat. Struct. Biol., 1995, 2(9), 790-6.
53. Nelson, M.R.; Chazin, W.J. Structures of EF-hand Ca(2+)-binding proteins: diversity in the organization, packing and response to Ca2+ binding. Biometals, 1998, 11(4), 297-318.
54. Sastry, M.; Ketchem, R.R.; Crescenzi, O.; Weber, C.; Lubienski, M.J.; Hidaka, H.; Chazin, W.J. The three-dimensional structure of Ca(2+)-bound calcyclin: implications for Ca(2+)-signal transduction by S100 proteins. Structure, 1998, 6(2), 223-231.
55. Bhattacharya, S.; Large, E.; Heizmann, C.W.; Hemmings, B.; Chazin, W.J. Structure of the Ca2+/S100B/NDR kinase peptide complex: insights into S100 target specificity and activation of the kinase. Biochemistry, 2003, 42(49), 14416-14426.
56. Maler, L.; Sastry, M.; Chazin, W.J. A structural basis for S100 protein specificity derived from comparative analysis of apo and Ca(2+)-calcyclin. J. Mol. Biol., 2002, 317(2), 279-290.
57. Rety, S.; Sopkova, J.; Renouard, M.; Osterloh, D.; Gerke, V.; Tabaries, S.; Russo-Marie, F.; Lewit-Bentley, A. The crystal structure of a complex of p11 with the annexin II N-terminal peptide. Nat. Struct. Biol., 1999, 6(1), 89-95.
58. Rustandi, R.R.; Baldisseri, D.M.; Weber, D.J. Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat. Struct. Biol., 2000, 7(7), 570-574.
59. Smith, S.P.; Shaw, G.S. A novel calcium-sensitive switch revealed by the structure of human S100B in the calcium-bound form. Structure, 1998, 6(2), 211-222.
60. Brodersen, D.E.; Nyborg, J.; Kjeldgaard M. Zinc-binding site of an S100 protein revealed:two crystal structures of Ca2+-bound human psoriasin (S100A7) in the Zn2+-loaded and Zn2+-free states. Biochemistry, 1999, 38(6), 1695-1704.
61. Moroz, O.V.; Antson, A.A.; Grist, S.J.; Maitland, N.J.; Dodson, G.G.; Wilson, K.S.; Lukanidin, E.; Bronstein, I.B. Structure of the human S100A12-copper complex: implications for host-parasite defence. Acta Crystallogr. D Biol. Crystallogr., 2003, 59(Pt 5), 859-867.
62. Moroz, O.V.; Blagova, E.V.; Wilkinson, A.J.; Wilson, K.S.; Bronstein, I.B. The crystal structures of human S100A12 in apo form and in complex with zinc: new insights into S100A12 oligomerisation. J. Mol. Biol., 2009, 391(3), 536-551.
63. Wilder, P.T.; Varney, K.M.; Weiss, M.B.; Gitti, R.K., Weber, D.J. Solution structure of zinc- and calcium-bound rat S100B as determined by nuclear magnetic resonance spectroscopy. Biochemistry, 2005, 44(15), 5690-5702.
64. Korndorfer, I.P.; Brueckner, F., Skerra, A. The crystal structure of the human (S100A8/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins. J. Mol. Biol., 2007, 370(5), 887-898.
65. Sopalla, C.; Leukert, N.; Sorg, C., Kerkhoff, C. Evidence for the involvement of the unique C-tail of S100A9 in the binding of arachidonic acid to the heterocomplex S100A8/A9. Biol. Chem., 2002, 383(12), 1895-1905.
66. Corbin, B.D. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science, 2008, 319(5865), 962-965.
67. Newton, R.A., Hogg, N. The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J. Immunol., 1998, 160(3), 1427-1435.
68. Srikrishna, G.; Panneerselvam, K.; Westphal,V.; Abraham,V.; Varki, A.;reeze, H.H. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J. Immunol., 2001, 166(7), 4678-4688.
69. Robinson, M.J.; Tessier, P.; Poulsom, R., Hogg, N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem., 2002, 277(5), 3658-3665.
70. Koike, T.; K. Kondo; T. Makita; K. Kajiyama; Yoshida,Y.; Morikawa, M. Intracellular localization of migration inhibitory factorrelated protein (MRP) and detection of cell surface MRP binding sites on human leukemia cell lines. J. Biochem., 1998, 123(6), 1079-1087.
71. Ott, M.; Gogvadze,V.; Orrenius,S., Zhivotovsky,B. Mitochondria, oxidative stress and cell death. Apoptosis, 2007, 12(5), 913-22.
72. Anderson, S.; Bankier, A.T.; Barrell, B.G.; de Bruijn, M.H.; Coulson, A.R.; Drouin, J.; Eperon, I.C.; Nierlich, D.P.; Roe, B.A.; Sanger, F.; Schreier, P.H.; Smith, A.J.; Staden, R.; Young, I.G. Sequence and organization of the human mitochondrial genome. Nature, 1981, 290(5806), 457-465.
73. Chen, J.J.; Bertrand, H.; Yu. B.P. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic. Biol. Med., 1995, 19(5), 583-590.
74. Mikami, M.; Yamazaki, M., Yui, S. Kinetical analysis of tumor cell death-inducing mechanism by polymorphonuclear leukocytederived calprotectin: involvement of protein synthesis and generation of reactive oxygen species in target cells. Microbiol. Immunol., 1998, 42(3), 211-221.
75. Zamzami, N.; Marchetti, P.; Castedo, M.; Zanin, C.; Vayssiere, J.L.; Petit, P.X., Kroemer, G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med., 1995, 181(5), 1661-1672.
76. Letai, A.; Bassik, M.C.; Walensky, L.D.; Sorcinelli, M.D; Weiler, S., Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell, 2002, 2(3), 183-192.
77. Wei, M.C.; Zong, W.X.; Cheng, E.H.; Lindsten, T.; Panoutsakopoulou, V.; Ross, A.J.; Roth, K.A.; MacGregor, G.R.; Thompson, C.B.; Korsmeyer, S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 2001, 292(5517), 727-730.
78. Oltersdorf, T.; Elmore, S.W.; Shoemaker, A.R.; Armstrong, R.C.; Augeri, D.J.; Belli, B.A.; Bruncko, M.; Deckwerth, T.L.; Dinges, J.; Hajduk, P.J.; Joseph, M.K.; Kitada, S.; Korsmeyer, S.J.; Kunzer, A.R.; Letai, A.; Li, C.; Mitten, M.J.; Nettesheim, D.G.; Ng, S.; Nimmer, P.M.; O'Connor, J.M.; Oleksijew, A.; Petros, A.M.; Reed, J.C.; Shen, W.; Tahir, S.K.; Thompson, C.B.; Tomaselli, K.J.; Wang, B.; Wendt, M.D.; Zhang, H.; Fesik, S.W.; Rosenberg, S.H. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature, 2005, 435(7042), 677-681.
79. Gottlieb, R.A. Mitochondria: execution central. FEBS Lett., 2000, 482(1-2), 6-12.
80. Daniel, P.T.; Schulze-Osthoff, K.; Belka, C., Guner, D. Guardians of cell death: the Bcl-2 family proteins. Essays Biochem., 2003, 39, 73-88.
81. Green, D., Kroemer, G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol., 1998, 8(7), 267-271.
82. Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev., 2001, 15(22), 2922-2933.
83. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 1997, 3(6), 614-20.
84. Ferri, K.F., Kroemer,G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol., 2001, 3(11), E255-63.
85. Danial, N.N., Korsmeyer, S.J. Cell death: critical control points. Cell, 2004, 116(2), 205-219.
86. Ekert, P.G., Vaux, D.L. The mitochondrial death squad: hardened killers or innocent bystanders? Curr. Opin. Cell Biol., 2005, 17(6), 626-630.
87. Brenner, C., Kroemer, G. Apoptosis. Mitochondria--the death signal integrators. Science, 2000, 289(5482), 1150-1151.
88. Green, D.R., Reed, J.C. Mitochondria and apoptosis. Science, 1998, 281(5381), 1309-1312.
89. Croce, K.; Gao, H.; Wang, Y.; Mooroka, T.; Sakuma, M.; Shi, C.; Sukhova, G.K.; Packard, R.R.; Hogg, N.; Libby, P.; Simon, D.I. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation, 2009, 120(5), 427-436.
90. Sinha, P.; Okoro, C.; Foell, D.; Freeze, H.H.; Ostrand-Rosenberg, S., Srikrishna, G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol., 2008, 181(7), 4666-4675.
91. Cheng, P.; Corzo, C.A.; Luetteke, N.; Yu, B.; Nagaraj, S.; Bui, M.M.; Ortiz, M.; Nacken, W.; Sorg, C.; Vogl, T.; Roth, J.; Gabrilovich, D.I. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med., 2008, 205(10), 2235-2249.
92. Nemeth, J.; Stein, I.; Haag, D.; Riehl, A.; Longerich, T.; Horwitz, E.; Breuhahn, K.; Gebhardt, C.; Schirmacher, P.; Hahn, M.; Ben-Neriah, Y.; Pikarsky, E.; Angel, P.; Hess, J. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology, 2009, 50(4), 1251-1262.
93. Li, C.; Chen, H.; Ding, F.; Zhang, Y.; Luo, A.; Wang, M., Liu, Z. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. Biochem. J., 2009, 422(2), 363-372.
94. Bjork, P.; Bjork, A.; Vogl, T.; Stenstrom, M.; Liberg, D.; Olsson, A.; Roth, J.; Ivars, F.; Leanderson, T. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3- carboxamides. PLoS Biol., 2009, 7(4), e97.